Oral Contraceptives and Breast Cancer: A review with some comments on mathematical models

References

• Kelsey J L, Berkowitz G S. Breast cancer epidemiology. Cancer Res 1988; 48: 5615–23
   PubMed Web of Science ®Google Scholar
• Boyle P, Leake R. Progress in understanding breast cancer: epidemiological and biological interactions. Breast Cancer Res Treat 1988; 11: 91–112
   PubMed Web of Science ®Google Scholar
• Adami H-O, Adams G, Boyle P, et al. Breast cancer etiology. Chapter II. Int J Cancer 1991, suppl 5: 22–39
   Google Scholar
• Kalache A, McPherson K, Barltrop K, Vessey M P. Oral contraceptives and breast cancer. Br J Hosp Med 1983; 30: 278–83
   PubMed Web of Science ®Google Scholar
• Christoflersen T, Lund E, Nesheim B-I, Bergsjø P, Johansson E DB, Meirik O. Oral contraceptives and risk of cancer. Oral contraception. Svenska Socialstyrelsen, Stockholm 1984
   Google Scholar
• Pike M C, Chilvers C. Oral contraceptives and breast cancer: the current controversy. JRSH 1985; 1: 5–10
   Google Scholar
• Huggins G R, Zucker P K. Oral contraceptives and neoplasia: 1987 update. Fertil Steril 1987; 47: 733–61
   PubMedGoogle Scholar
• Holck S. Hormonal contraceptives and the risk of cancer. World Health Stat Q 1987; 40: 225–32
   PubMedGoogle Scholar
• Schlesselman J J. Cancer of the breast and reproductive tract in relation to use of oral contraceptives. Contraception 1989; 40: 1–38
   PubMed Web of Science ®Google Scholar
• Olsson H. Oral contraceptives and breast cancer. A review. Acta Oncol 1989; 28: 849–63
   PubMed Web of Science ®Google Scholar
• Doll R. What conclusions can we reach and how do we best assist women to take informed choices regarding their use of oral contraceptives. Oral contraceptives and breast cancer, R D Mann. Parthenon Publ., London 1990; 395–400
   Google Scholar
• Chilvers C ED, Deacon J M. Oral contraceptives and breast cancer. Br J Cancer 1990; 61: 1–4
   PubMedGoogle Scholar
• Leeuwen F E, van Rookus M A. The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer. Eur J Cancer Clin One 1989; 25: 1961–72
   PubMedGoogle Scholar
• Prentice R L, Thomas D B. On the epidemiology of oral contraceptives and disease. Adv Res Cancer 1987; 49: 285–401
   PubMed Web of Science ®Google Scholar
• Romieu I, Berlin J A, Colditz G. Oral contraceptives and breast cancer. Review and meta-analysis. Cancer 1990; 66: 2253–63
   PubMed Web of Science ®Google Scholar
• UK National Case-Control Study Group. Oral contraceptive use and breast cancer risk in young women. Lancet 1989; 1: 973–82
   PubMedGoogle Scholar
• WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and combined oral contraceptives: results from a multinational study. Br J Cancer 1990; 61: 110–9
   PubMedGoogle Scholar
• Editorial. Breast cancer and the pill – a muted reassurance. BMJ 1981; 282: 2075–6
   PubMedGoogle Scholar
• Editorial. Sex hormones and gynaecological cancer. BMJ 1982; 284: 1657–8
   PubMedGoogle Scholar
• Editorial. Oral contraceptives and neoplasia. Lancet 1983; 2: 947–8
   PubMedGoogle Scholar
• Editorial. Which pill?. BMJ 1983; 287: 1397–8
   PubMedGoogle Scholar
• Editorial. Another look at the pill and breast cancer. Lancet 1985; 2: 985–6
   PubMedGoogle Scholar
• Editorial. The pill and breast cancer: why the uncertainty?. BMJ 1986; 293: 709–10
   PubMedGoogle Scholar
• Editorial. Oral contraceptives and breast cancer. Lancet 1986; 2: 665–6
   PubMedGoogle Scholar
• Editorial. Oral contraceptives–time to take stock. N Eng J Med 1986; 315: 450–1
   PubMedGoogle Scholar
• Editorial. The contraceptive pill and breast cancer in young women. Evidence is still reassuring. BMJ 1989; 298: 1269–70
   PubMedGoogle Scholar
• Editorial. Cancer risks of oral contraceptives. Lancet 1989; 1: 84
   PubMedGoogle Scholar
• Editorial. Cancer risks of oral contraceptives. Lancet 1989; 1: 21–2
   PubMedGoogle Scholar
• Editorial. Case/controls, breast cancer and the pill. Lancet 1989; 1: 1000
   Google Scholar
• Skegg D CG. Potential for bias in case-control studies of oral contraceptives and breast cancer. Am J Epidemiol 1988; 127: 205–12
   PubMed Web of Science ®Google Scholar
• Lund E. Re: Potential for bias in cast-control studies of oral contraceptives and breast cancer. Am J Epidemiol 1989; 130: 1066–8
   PubMedGoogle Scholar
• Lund E. Oral contraceptive use and breast cancer in young women–the validity of different control groups in case-control study. J Clin Epidemiol 1989; 42: 987–93
   PubMedGoogle Scholar
• Stadel B V, Schlesselman J J. Oral contraceptives and breast cancer. Lancet 1986; 2: 922–3, (letter)
   PubMedGoogle Scholar
• Miller D R, Rosenberg L, Kaufman D W, Stolley P, Warshauer M, Shapiro S. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol 1989; 129: 269–80
   PubMed Web of Science ®Google Scholar
• Clavel F, Andrieu N, Gairard B, et al. Oral contraceptives and breast cancer: a French case-control study. Int J Epidemiol 1991; 20: 32–8
   PubMedGoogle Scholar
• Lund E, Jacobsen B K. Use of oral contraceptives in relation to dietary habits and alcohol consumption. Contraception 1990; 42: 171–7
   PubMedGoogle Scholar
• UK National Case-Control Study Group. Oral contraceptive use and breast cancer in young women: subgroup analyses. lancet 1990; 1: 1507–9
   Google Scholar
• Adami H-O, Lund E, Bergstrom R, Meirik O. Cigarette smoking, alcohol consumption and risk of breast cancer in young women. Br J Cancer 1988; 58: 832–7
   PubMed Web of Science ®Google Scholar
• Chilver C, Peo J, Pike M C, McPherson K, Vessey M P. Oral contraceptives, breast cancer, and lactation. Lancet 1989; 2: 1163–4, (letter)
   PubMedGoogle Scholar
• Breslow N E, Day N E. Statistical methods in cancer research. Vol 1–The analysis of case-control studies. IARC, Lyon 1980, IARC Sci Publ No. 32
   Google Scholar
• Rothman K J. Modern epidemiology. Little, Brown and Company, Boston 1986
   Google Scholar
• Lund E, Meirik O, Adami H-O, Christoffersen T. Update of the Swedish-Norwegian case-control study on oral contraceptive use and breast cancer in young women: the possible role of bias. Oral contraceptives and breast cancer, R D Mann. Parthenon Publ., London 1990; 99–107
   Google Scholar
• The Norwegian Cancer Registry. Incidence of cancer in Norway 1982–1986. The Norwegian Cancer Registry, Oslo 1989
   Google Scholar
• Lund E. Breast cancer mortality and the change in fertility risk factors at menopause. A prospective study of 800 000 married Norwegian women. Epidemiology 1991; 2: 285–8
   PubMedGoogle Scholar
• Meirik O, Lund E, Adami H-O, Bergström R, Christotfersen T, Bergsjø P. Oral contraceptive use and breast cancer. Lancet 1986; 2: 650–4
   PubMed Web of Science ®Google Scholar
• Meirik O, Farley T MM, Lund E, Adami H-O, Christoffersen T, Bergsjø P. Breast cancer and oral contraceptives: patterns of risk among parous and nulliparous women. Further analysis of the Swedish-Norwegian material. Contraception 1989; 39: 471–5
   PubMedGoogle Scholar
• Leon D A. A prospective study of the independent effects of parity and age at first birth on breast cancer incidence in England and Wales. Int J Cancer 1989; 43: 986–91
   PubMed Web of Science ®Google Scholar
• Tulinius H, Sigvaldason H, Hrafnkelsson G, Tryggvadottir L, Sigurdsson K. Reproductive factors and breast cancer risk in Iceland. A second cohort study. Int J Cancer 1990; 46: 972–5
   PubMedGoogle Scholar
• Olsson H, Ranstam J, Baldetorp M A, et al. Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and abortion. Cancer 1991; 67: 1285–90
   PubMedGoogle Scholar
• Going J J, Anderson T J, Battersby S, Macintyre C CA. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 1988; 130: 193–204
   PubMed Web of Science ®Google Scholar